US 10322146
Methods of conditioning patients for T cell therapy
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 10322146 (Methods of conditioning patients for T cell therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K31/664